Recombinant human growth hormone treatment of Floating-Harbor syndrome: a case report and literature review
Abstract Background Floating Harbor syndrome (FHS) is a rare genetic disorder with over 100 reported cases worldwide and less than 30 treated with recombinant human growth hormone (rhGH). This article reports the clinical characteristics of a child with FHS and the effect of rhGH on height increase....
Saved in:
Main Authors: | Qing He, Yi Deng, Lei Xu, Zhe Xu, Yi Ding, Menghui Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Pediatrics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12887-025-05437-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Human growth hormone therapy – in three stages: past, present, and future
by: Maciej Hilczer, et al.
Published: (2024-07-01) -
Interpreting IGF-1 in children treated with recombinant growth hormone: challenges during early puberty
by: Helena-Jamin Ly, et al.
Published: (2025-01-01) -
GH Therapy in Non–Growth Hormone-Deficient Children
by: Chiara Guzzetti, et al.
Published: (2024-12-01) -
Efficacy in Japanese adults with growth hormone deficiency receiving weekly somapacitan or daily growth hormone: results from phase 3 REAL 1 trial
by: Fumio Otsuka, et al.
Published: (2025-02-01) -
Diurnal Variation of Chemical Characteristics and Source Identification of Fine Particles in the Kaohsiung Harbor
by: Yu-Lun Tseng, et al.
Published: (2022-05-01)